2018 news stories

Landing listing
Date

In August 2018, Kyle Alexander was appointed by co-option to the Board of Trustees, bringing a Northern Ireland presence to the board.

Date

Researchers in America have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's in a mouse model of the condition.

Date

Further analysis of the results from a recent clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's has revealed encouraging signs of a positive effect on mood.

Date

To mark World Parkinson's Day on 11 April, we teamed up with the European Parkinson's Disease Association and other organisations around the world to #UniteForParkinsons, a global campaign that aimed to show what Parkinson's truly is.

Date

Parkinson's UK has released new figures on the number of people with the condition. What do they mean for bringing forward the day no one fears Parkinson's?

Date

We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.